Validation of a microfluidic platform to measure total therapeutic antibodies and incurred sample reanalysis performance.

BACKGROUND A microfluidic platform-based assay was validated to measure a humanized or fully human IgG in rat serum samples. MATERIALS & METHODS The cumulative assessment for accuracy and precision was performed with three accuracy and precision runs. RESULTS The inter-assay accuracy (mean %bias) ranged from -4.3 to 3.8%, and inter-batch %CV ranged from 5.0 to 9.2%. The method acceptance criterion was determined as 15% total error. The assay dynamic range was 50 to 10000 ng/ml. Incurred sample reanalysis passed with 95% of samples meeting incurred sample reanalysis acceptance criteria. Potential carryover effect was not observed. CONCLUSION This study demonstrated the need for evaluating additional platform-specific processes when new technologies are employed to ensure the reproducibility of a successfully validated microfluidic platform method.

[1]  Xun Wang,et al.  Validation of a Gyrolab™ assay for quantification of rituximab in human serum. , 2012, Journal of pharmacological and toxicological methods.

[2]  Mark Ma,et al.  Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: benefits and limitations in assay range. , 2010, Journal of pharmaceutical and biomedical analysis.

[3]  K. Stubenrauch,et al.  Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates. , 2009, Journal of pharmaceutical and biomedical analysis.

[4]  Orawon Chailapakul,et al.  Nanoparticle-based electrochemical detection in conventional and miniaturized systems and their bioanalytical applications: a review. , 2011, Analytica chimica acta.

[5]  M. Glennie,et al.  Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum. , 2010, Journal of immunological methods.

[6]  Lee Abberley,et al.  The Gyrolab™ immunoassay system: a platform for automated bioanalysis and rapid sample turnaround. , 2013, Bioanalysis.

[7]  Mark Ma,et al.  Implementation of a universal analytical method in early-stage development of human antibody therapeutics: application to pharmacokinetic assessment for candidate selection. , 2012, Bioanalysis.

[8]  Pamela M Whalen,et al.  Development and validation of an alpha fetoprotein immunoassay using Gyros technology. , 2012, Journal of pharmaceutical and biomedical analysis.

[9]  Binodh DeSilva,et al.  Recommendations for the Bioanalytical Method Validation of Ligand-Binding Assays to Support Pharmacokinetic Assessments of Macromolecules , 2003, Pharmaceutical Research.

[10]  L. Blum,et al.  Chemiluminescent enzyme immunoassays: a review of bioanalytical applications. , 2009, Bioanalysis.

[11]  Lora Hamuro,et al.  Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis. , 2011, Journal of pharmacological and toxicological methods.